Term Description

Type of therapy that is unrelated to a patient's diagnosis but is related to the specific genetic variant identified. To report a type of therapy that is related to the variant identified and directly related to the patient's diagnosis, use LOINC 93348-1.

LOINC Names Get Info

Fully-Specified Name
Available treatment related to genetic variant and not to patient diagnosis:Prid:Pt:Bld/Tiss:Nom:
Long Common Name
Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal
Short Name
Avail tx for variant but not dx Bld/T
Display Name
Available treatment related to genetic variant and not to patient diagnosis Nom (Bld/Tiss)
Consumer Name Alpha Get Info
Available treatment related to genetic variant and Not to patient diagnosis, Blood or tissue specimen

Part Model Get Info

  • Component
    Available treatment related to genetic variant and not to patient diagnosis
    LP411098-9
    • Analyte
      Available treatment related to genetic variant and not to patient diagnosis
      LP411098-9
      • Component Numerator
        Available treatment related to genetic variant and not to patient diagnosis
        LP411098-9
        • Component Numerator Core
          Available treatment related to genetic variant and not to patient diagnosis
          LP411098-9
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Prid
    LP6850-4
  • Time
    Pt
    LP6960-1
  • System
    Bld/Tiss
    LP7061-7
    • System Core
      Bld/Tiss
      LP7061-7
    • Super System
      NULL
       
  • Scale
    Nom
    LP7750-5
  • Method
    NULL
     

Example Answer List: LL5374-5

Source: Quest Diagnostics Inc.
AnswerCodeScoreAnswer ID
BinimetinibLA30251-5
ImatinibLA30253-1
SunitinibLA30250-7
TrametinibLA30252-3
MidostaurinLA30247-3
SorafenibLA30248-1
PonatinibLA30249-9

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.67
Last Updated
Version 2.67 (ADD)
Order vs. Observation
Observation

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Dostupná léčba na základě genetické varianty a ne diagnózy pacienta:Přítomnost nebo identita:Časový bod:Krev/tkáň:Nominální:
el-GRGreek (Greece)Διαθέσιμη θεραπεία που σχετίζεται με τη γενετική παραλλαγή και όχι με τη διάγνωση του ασθενούς:Prid:Pt:Αίμα/Ιστός:Nom:
Synonyms: MOLPATH Nom Prid Pt Αίμα Αίμα/Ιστός Διάγνωση Διαθέσιμη θεραπεία που σχετίζεται με τη γενετική παραλλαγή και όχι με τη διάγνωση του ασθενούς Ιστός
es-ESSpanish (Spain)Tratamiento disponible relacionado con la variante genética y no con el diagnóstico del paciente:Presencia o identidad:Punto temporal:Sangre o tejido:Nom:
es-MXSpanish (Mexico)Tratamiento disponible relacionado con la variante genética y no con el diagnóstico del paciente:Presencia o identidad:Punto temporal:Sangre o tejido:Nominal:
fr-FRFrench (France)Traitement disponible lié à la variante génétique et non au diagnostic du patient:Identification:Ponctuel:Sang/Tissu:Résultat nominal:
it-ITItalian (Italy)Trattamento disponibile correlato alla variante genetica e non alla diagnosi del paziente:Prid:Pt:Sangue/Tess:Nom:
Synonyms: Patologia molecolare Presenza o Identità Punto nel tempo (episodio) Sangue Sangue o Tessuto Tessuto & Strisci
zh-CNChinese (China)与遗传变异相关但与患者诊断并不相关的可用治疗:存在与否或特征标识:时间点:全血/组织:名义型:
Synonyms: 与遗传变异(遗传性变异、基因变异、传性变型、遗传变异体、基因变异体)相关但与患者(病人、病患、病号、伤病员)诊断(病情、疾病、疾患)并不(不)相关的可用(现成可用、现成)治疗(治疗方法、治疗方法);与遗传变异相关但不与患者诊断相关的可用治疗;与遗传变异相关但与患者诊断无关的可用治疗 全血或组织;血液/组织;血液或组织 分子病理学;分子病理学试验 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 存在;存在与否;特征标识;身份;身份标识 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 血;血液 诊断结论;判断;结论

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=93347-3